Haemopoietic progenitor and myeloid cell kinetics in humans treated with interleukin-3 and granulocyte/macrophage colony-stimulating factor in combination
- 15 November 1994
- journal article
- clinical trial
- Published by Wiley in International Journal of Cancer
- Vol. 59 (4) , 483-490
- https://doi.org/10.1002/ijc.2910590409
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Interleukin-3 in vivo: kinetic of response of target cellsBlood, 1993
- Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony- stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I studyBlood, 1992
- Haemopoietic cell kinetics in humans treated with rGM‐CSFInternational Journal of Cancer, 1992
- Recombinant human stem cell factor stimulates increased numbers of peripheral blood and marrow CFU-GM, BFU-E, CFU-MIX, HPP-CFC and CD34 + cells in baboonsThe International Journal of Cell Cloning, 1992
- Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivoBlood, 1991
- Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failureBlood, 1990
- The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo.Proceedings of the National Academy of Sciences, 1989
- Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor.Journal of Clinical Investigation, 1989
- Human IL-3 and GM-CSF Act Synergistically in Stimulating Hematopoiesis in PrimatesScience, 1988